Evidence map›Paper›PMID 26719687›Full record

ArticleInternational journal of nanomedicine2015

Therapeutic and scintigraphic applications of polymeric micelles: combination of chemotherapy and radiotherapy in hepatocellular carcinoma.

Ying-Hsia Shih, Cheng-Liang Peng, Ping-Fang Chiang, Wuu-Jyh Lin, Tsai-Yueh Luo, Ming-Jium Shieh

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Linking In Vivo Imaging to Therapeutic Outcome withInternational journal of molecular sciences · 2026
    Review
  2. Exploring the Therapeutic Potential ofInternational journal of molecular sciences · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Diffusion-weighted MRI andEuropean journal of nuclear medicine and molecular imaging · 2019
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ying-Hsia ShihInstitute of Biomedical Engineering, National Taiwan University, Taipei, Taiwan ; Isotope Application Division, Institute of Nuclear Energy Research, Taoyuan, Taiwan.
Cheng-Liang PengIsotope Application Division, Institute of Nuclear Energy Research, Taoyuan, Taiwan.
Ping-Fang ChiangInstitute of Biomedical Engineering, National Taiwan University, Taipei, Taiwan ; Isotope Application Division, Institute of Nuclear Energy Research, Taoyuan, Taiwan.
Wuu-Jyh LinIsotope Application Division, Institute of Nuclear Energy Research, Taoyuan, Taiwan.
Tsai-Yueh LuoIsotope Application Division, Institute of Nuclear Energy Research, Taoyuan, Taiwan ; Institute of Radiological Science, Central University, Taichung, Taiwan.
Ming-Jium ShiehInstitute of Biomedical Engineering, National Taiwan University, Taipei, Taiwan ; Department of Oncology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
Institute of Nuclear Energy Research · TWNational Taiwan University · TWCentral Taiwan University of Science and Technology · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study evaluated a multifunctional micelle simultaneously loaded with doxorubicin (Dox) and labeled with radionuclide rhenium-188 ((188)Re) as a combined radiotherapy and chemotherapy treatment for hepatocellular carcinoma. We investigated the single photon emission computed tomography, biodistribution, antitumor efficacy, and pathology of (188)Re-Dox micelles in a murine orthotopic luciferase-transfected BNL tumor cells hepatocellular carcinoma model. The single photon emission computed tomography and computed tomography images showed high radioactivity in the liver and tumor, which was in agreement with the biodistribution measured by γ-counting. In vivo bioluminescence images showed the smallest size tumor (P<0.05) in mice treated with the combined micelles throughout the experimental period. In addition, the combined (188)Re-Dox micelles group had significantly longer survival compared with the control, (188)ReO4 alone (P<0.005), and Dox micelles alone (P<0.01) groups. Pathohistological analysis revealed that tumors treated with (188)Re-Dox micelles had more necrotic features and decreased cell proliferation. Therefore, (188)Re-Dox micelles may enable combined radiotherapy and chemotherapy to maximize the effectiveness of treatment for hepatocellular carcinoma.

Indexed as

Drug Delivery SystemsAnimalsAntibiotics, AntineoplasticCarcinoma, HepatocellularCell Line, TumorCell ProliferationCombined Modality TherapyDoxorubicinFemaleLiver NeoplasmsMiceMice, Inbred BALB CMicellesMice, NudePolymersRadiopharmaceuticalsAntibiotics, AntineoplasticDoxorubicinMicellesPolymersRadiopharmaceuticalsRhenium188Re-Dox micelleschemotherapeutichepatocellular carcinomaradiotherapeutic

Identifiers

PMID26719687
PMCPMC4687727
OpenAlexW2219053479

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.